2018 -- S 2545 SUBSTITUTE A | |
======== | |
LC004868/SUB A/2 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2018 | |
____________ | |
A N A C T | |
RELATING TO HEALTH AND SAFETY -- INSURANCE COVERAGE FOR MENTAL | |
ILLNESS AND SUBSTANCE ABUSE | |
| |
Introduced By: Senators Miller, Goldin, Calkin, Satchell, and Paolino | |
Date Introduced: March 01, 2018 | |
Referred To: Senate Health & Human Services | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Section 5-37.3-4 of the General Laws in Chapter 5-37.3 entitled |
2 | "Confidentiality of Health Care Communications and Information Act" is hereby amended to read |
3 | as follows: |
4 | 5-37.3-4. Limitations on and permitted disclosures. |
5 | (a) (1) Except as provided in subsection (b) of this section, or as specifically provided by |
6 | the law, a patient's confidential health care information shall not be released or transferred |
7 | without the written consent of the patient, or his or her authorized representative, on a consent |
8 | form meeting the requirements of subsection (d) of this section. A copy of any notice used |
9 | pursuant to subsection (d) of this section, and of any signed consent shall, upon request, be |
10 | provided to the patient prior to his or her signing a consent form. Any and all managed care |
11 | entities and managed care contractors writing policies in the state shall be prohibited from |
12 | providing any information related to enrollees that is personal in nature and could reasonably lead |
13 | to identification of an individual and is not essential for the compilation of statistical data related |
14 | to enrollees, to any international, national, regional, or local medical information database. This |
15 | provision shall not restrict or prohibit the transfer of information to the department of health to |
16 | carry out its statutory duties and responsibilities. |
17 | (2) Any person who violates the provisions of this section may be liable for actual and |
18 | punitive damages. |
| |
1 | (3) The court may award a reasonable attorney's fee at its discretion to the prevailing |
2 | party in any civil action under this section. |
3 | (4) Any person who knowingly and intentionally violates the provisions of this section |
4 | shall, upon conviction, be fined not more than five thousand ($5,000) dollars for each violation, |
5 | or imprisoned not more than six (6) months for each violation, or both. |
6 | (5) Any contract or agreement that purports to waive the provisions of this section shall |
7 | be declared null and void as against public policy. |
8 | (b) No consent for release or transfer of confidential health care information shall be |
9 | required in the following situations: |
10 | (1) To a physician, dentist, or other medical personnel who believes, in good faith, that |
11 | the information is necessary for diagnosis or treatment of that individual in a medical or dental |
12 | emergency; |
13 | (2) To medical and dental peer review boards, or the board of medical licensure and |
14 | discipline, or board of examiners in dentistry; |
15 | (3) To qualified personnel for the purpose of conducting scientific research, management |
16 | audits, financial audits, program evaluations, actuarial, insurance underwriting, or similar studies; |
17 | provided, that personnel shall not identify, directly or indirectly, any individual patient in any |
18 | report of that research, audit, or evaluation, or otherwise disclose patient identities in any manner; |
19 | (4) (i) By a health care provider to appropriate law enforcement personnel, or to a person |
20 | if the health care provider believes that person, or his or her family, is in danger from a patient; or |
21 | to appropriate law enforcement personnel if the patient has, or is attempting to obtain, narcotic |
22 | drugs from the health care provider illegally; or to appropriate law enforcement personnel, or |
23 | appropriate child protective agencies, if the patient is a minor child or the parent or guardian of |
24 | said child and/or the health care provider believes, after providing health care services to the |
25 | patient, that the child is, or has been, physically, psychologically, or sexually abused and |
26 | neglected as reportable pursuant to § 40-11-3; or to appropriate law enforcement personnel or the |
27 | division of elderly affairs if the patient is an elder person and the healthcare provider believes, |
28 | after providing healthcare services to the patient, that the elder person is, or has been, abused, |
29 | neglected, or exploited as reportable pursuant to § 42-66-8; or to law enforcement personnel in |
30 | the case of a gunshot wound reportable under § 11-47-48; |
31 | (A) Provided further, consistent with applicable law and standards of ethical conduct, a |
32 | health care provider may disclose a patient’s protected health information related to a substance |
33 | use disorder to a person or persons if: |
34 | (I) The health care provider, in good faith, believes the use or disclosure is necessary to |
| LC004868/SUB A/2 - Page 2 of 13 |
1 | prevent or lessen a serious and imminent threat to the patient’s health through continued |
2 | substance use upon discharge; and |
3 | (II) Is to a person or persons reasonably able to prevent or lessen the threat of continued |
4 | substance use upon discharge; |
5 | (ii) A health care provider may disclose protected health information in response to a law |
6 | enforcement official's request for such information for the purpose of identifying or locating a |
7 | suspect, fugitive, material witness, or missing person, provided that the health care provider may |
8 | disclose only the following information: |
9 | (A) Name and address; |
10 | (B) Date and place of birth; |
11 | (C) Social security number; |
12 | (D) ABO blood type and rh factor; |
13 | (E) Type of injury; |
14 | (F) Date and time of treatment; |
15 | (G) Date and time of death, if applicable; and |
16 | (H) A description of distinguishing physical characteristics, including height, weight, |
17 | gender, race, hair and eye color, presence or absence of facial hair (beard or moustache), scars, |
18 | and tattoos. |
19 | (I) Except as permitted by this subsection, the health care provider may not disclose for |
20 | the purposes of identification or location under this subsection any protected health information |
21 | related to the patient's DNA or DNA analysis, dental records, or typing, samples, or analysis of |
22 | body fluids or tissue. |
23 | (iii) A health care provider may disclose protected health information in response to a law |
24 | enforcement official's request for such information about a patient who is, or is suspected to be, a |
25 | victim of a crime, other than disclosures that are subject to subsection (b)(4)(vii) of this section, |
26 | if: |
27 | (A) The patient agrees to the disclosure; or |
28 | (B) The health care provider is unable to obtain the patient's agreement because of |
29 | incapacity or other emergency circumstances provided that: |
30 | (1) The law enforcement official represents that such information is needed to determine |
31 | whether a violation of law by a person other than the victim has occurred, and such information is |
32 | not intended to be used against the victim; |
33 | (2) The law enforcement official represents that immediate law enforcement activity that |
34 | depends upon the disclosure would be materially and adversely affected by waiting until the |
| LC004868/SUB A/2 - Page 3 of 13 |
1 | patient is able to agree to the disclosure; and |
2 | (3) The disclosure is in the best interests of the patient as determined by the health care |
3 | provider in the exercise of professional judgment. |
4 | (iv) A health care provider may disclose protected health information about a patient who |
5 | has died to a law enforcement official for the purpose of alerting law enforcement of the death of |
6 | the patient if the health care provider has a suspicion that such death may have resulted from |
7 | criminal conduct. |
8 | (v) A health care provider may disclose to a law enforcement official protected health |
9 | information that the health care provider believes in good faith constitutes evidence of criminal |
10 | conduct that occurred on the premises of the health care provider. |
11 | (vi) (A) A health care provider providing emergency health care in response to a medical |
12 | emergency, other than such emergency on the premises of the covered health care provider, may |
13 | disclose protected health information to a law enforcement official if such disclosure appears |
14 | necessary to alert law enforcement to: |
15 | (1) The commission and nature of a crime; |
16 | (2) The location of such crime or of the victim(s) of such crime; and |
17 | (3) The identity, description, and location of the perpetrator of such crime. |
18 | (B) If a health care provider believes that the medical emergency described in subsection |
19 | (b)(4)(vi)(A) of this section is the result of abuse, neglect, or domestic violence of the individual |
20 | in need of emergency health care, subsection (b)(4)(vi)(A) of this section does not apply and any |
21 | disclosure to a law enforcement official for law enforcement purposes is subject to subsection |
22 | (b)(4)(vii) of this section. |
23 | (vii) (A) Except for reports permitted by subsection (b)(4)(i) of this section, a health care |
24 | provider may disclose protected health information about a patient the health care provider |
25 | reasonably believes to be a victim of abuse, neglect, or domestic violence to law enforcement or a |
26 | government authority, including a social service or protective services agency, authorized by law |
27 | to receive reports of such abuse, neglect, or domestic violence: |
28 | (1) To the extent the disclosure is required by law and the disclosure complies with, and |
29 | is limited to, the relevant requirements of such law; |
30 | (2) If the patient agrees to the disclosure; or |
31 | (3) To the extent the disclosure is expressly authorized by statute or regulation and: |
32 | (i) The health care provider, in the exercise of professional judgment, believes the |
33 | disclosure is necessary to prevent serious harm to the patient or other potential victims; or |
34 | (ii) If the patient is unable to agree because of incapacity, a law enforcement or other |
| LC004868/SUB A/2 - Page 4 of 13 |
1 | public official authorized to receive the report represents that the protected health information for |
2 | which disclosure is sought is not intended to be used against the patient and that an immediate |
3 | enforcement activity that depends upon the disclosure would be materially and adversely affected |
4 | by waiting until the patient is able to agree to the disclosure. |
5 | (B) A health care provider that makes a disclosure permitted by subsection (b)(4)(vii)(A) |
6 | of this section must promptly inform the patient that such a report has been, or will be, made, |
7 | except if: |
8 | (1) The health care facility, in the exercise of professional judgment, believes informing |
9 | the patient would place the individual at risk of serious harm; or |
10 | (2) The health care provider would be informing a personal representative, and the health |
11 | care provider reasonably believes the personal representative is responsible for the abuse, neglect, |
12 | or other injury, and that informing such person would not be in the best interests of the individual |
13 | as determined by the covered entity in the exercise of professional judgment. |
14 | (viii) The disclosures authorized by this subsection shall be limited to the minimum |
15 | amount of information necessary to accomplish the intended purpose of the release of |
16 | information. |
17 | (5) Between, or among, qualified personnel and health care providers within the health |
18 | care system for purposes of coordination of health care services given to the patient and for |
19 | purposes of education and training within the same health care facility; or |
20 | (6) To third party health insurers, including to utilization review agents as provided by § |
21 | 23-17.12-9(c)(4), third party administrators licensed pursuant to chapter 20.7 of title 27, and other |
22 | entities that provide operational support to adjudicate health insurance claims or administer health |
23 | benefits; |
24 | (7) To a malpractice insurance carrier or lawyer if the health care provider has reason to |
25 | anticipate a medical liability action; or |
26 | (8) (i) To the health care provider's own lawyer or medical liability insurance carrier if |
27 | the patient whose information is at issue brings a medical liability action against a health care |
28 | provider. |
29 | (ii) Disclosure by a health care provider of a patient's health care information that is |
30 | relevant to a civil action brought by the patient against any person or persons other than that |
31 | health care provider may occur only under the discovery methods provided by the applicable |
32 | rules of civil procedure (federal or state). This disclosure shall not be through ex parte contacts |
33 | and not through informal ex parte contacts with the provider by persons other than the patient or |
34 | his or her legal representative. |
| LC004868/SUB A/2 - Page 5 of 13 |
1 | Nothing in this section shall limit the right of a patient, or his or her attorney, to consult |
2 | with that patient's own physician and to obtain that patient's own health care information; |
3 | (9) To public health authorities in order to carry out their functions as described in this |
4 | title and titles 21 and 23 and rules promulgated under those titles. These functions include, but are |
5 | not restricted to, investigations into the causes of disease, the control of public health hazards, |
6 | enforcement of sanitary laws, investigation of reportable diseases, certification and licensure of |
7 | health professionals and facilities, review of health care such as that required by the federal |
8 | government and other governmental agencies; |
9 | (10) To the state medical examiner in the event of a fatality that comes under his or her |
10 | jurisdiction; |
11 | (11) In relation to information that is directly related to a current claim for workers' |
12 | compensation benefits or to any proceeding before the workers' compensation commission or |
13 | before any court proceeding relating to workers' compensation; |
14 | (12) To the attorneys for a health care provider whenever that provider considers that |
15 | release of information to be necessary in order to receive adequate legal representation; |
16 | (13) By a health care provider to appropriate school authorities of disease, health |
17 | screening, and/or immunization information required by the school; or when a school-age child |
18 | transfers from one school or school district to another school or school district; |
19 | (14) To a law enforcement authority to protect the legal interest of an insurance |
20 | institution, agent, or insurance-support organization in preventing and prosecuting the |
21 | perpetration of fraud upon them; |
22 | (15) To a grand jury, or to a court of competent jurisdiction, pursuant to a subpoena or |
23 | subpoena duces tecum when that information is required for the investigation or prosecution of |
24 | criminal wrongdoing by a health care provider relating to his, her or its provisions of health care |
25 | services and that information is unavailable from any other source; provided, that any information |
26 | so obtained, is not admissible in any criminal proceeding against the patient to whom that |
27 | information pertains; |
28 | (16) To the state board of elections pursuant to a subpoena or subpoena duces tecum |
29 | when that information is required to determine the eligibility of a person to vote by mail ballot |
30 | and/or the legitimacy of a certification by a physician attesting to a voter's illness or disability; |
31 | (17) To certify, pursuant to chapter 20 of title 17, the nature and permanency of a |
32 | person's illness or disability, the date when that person was last examined and that it would be an |
33 | undue hardship for the person to vote at the polls so that the person may obtain a mail ballot; |
34 | (18) To the central cancer registry; |
| LC004868/SUB A/2 - Page 6 of 13 |
1 | (19) To the Medicaid fraud control unit of the attorney general's office for the |
2 | investigation or prosecution of criminal or civil wrongdoing by a health care provider relating to |
3 | his, her or its provision of health care services to then-Medicaid-eligible recipients or patients, |
4 | residents, or former patients or residents of long-term residential care facilities; provided, that any |
5 | information obtained shall not be admissible in any criminal proceeding against the patient to |
6 | whom that information pertains; |
7 | (20) To the state department of children, youth and families pertaining to the disclosure |
8 | of health care records of children in the custody of the department; |
9 | (21) To the foster parent, or parents, pertaining to the disclosure of health care records of |
10 | children in the custody of the foster parent, or parents; provided, that the foster parent or parents |
11 | receive appropriate training and have ongoing availability of supervisory assistance in the use of |
12 | sensitive information that may be the source of distress to these children; |
13 | (22) A hospital may release the fact of a patient's admission and a general description of a |
14 | patient's condition to persons representing themselves as relatives or friends of the patient or as a |
15 | representative of the news media. The access to confidential health care information to persons in |
16 | accredited educational programs under appropriate provider supervision shall not be deemed |
17 | subject to release or transfer of that information under subsection (a) of this section; or |
18 | (23) To the workers' compensation fraud prevention unit for purposes of investigation |
19 | under §§ 42-16.1-12 -- 42-16.1-16. The release or transfer of confidential health care information |
20 | under any of the above exceptions is not the basis for any legal liability, civil or criminal, nor |
21 | considered a violation of this chapter; or |
22 | (24) To a probate court of competent jurisdiction, petitioner, respondent, and/or their |
23 | attorneys, when the information is contained within a decision-making assessment tool that |
24 | conforms to the provisions of § 33-15-47. |
25 | (c) Third parties receiving, and retaining, a patient's confidential health care information |
26 | must establish at least the following security procedures: |
27 | (1) Limit authorized access to personally identifiable, confidential health care |
28 | information to persons having a "need to know" that information; additional employees or agents |
29 | may have access to that information that does not contain information from which an individual |
30 | can be identified; |
31 | (2) Identify an individual, or individuals, who have responsibility for maintaining |
32 | security procedures for confidential health care information; |
33 | (3) Provide a written statement to each employee or agent as to the necessity of |
34 | maintaining the security and confidentiality of confidential health care information, and of the |
| LC004868/SUB A/2 - Page 7 of 13 |
1 | penalties provided for in this chapter for the unauthorized release, use, or disclosure of this |
2 | information. The receipt of that statement shall be acknowledged by the employee or agent, who |
3 | signs and returns the statement to his or her employer or principal, who retains the signed |
4 | original. The employee or agent shall be furnished with a copy of the signed statement; and |
5 | (4) Take no disciplinary or punitive action against any employee or agent solely for |
6 | bringing evidence of violation of this chapter to the attention of any person. |
7 | (d) Consent forms for the release or transfer of confidential health care information shall |
8 | contain, or in the course of an application or claim for insurance be accompanied by a notice |
9 | containing, the following information in a clear and conspicuous manner: |
10 | (1) A statement of the need for and proposed uses of that information; |
11 | (2) A statement that all information is to be released or clearly indicating the extent of the |
12 | information to be released; and |
13 | (3) A statement that the consent for release or transfer of information may be withdrawn |
14 | at any future time and is subject to revocation, except where an authorization is executed in |
15 | connection with an application for a life or health insurance policy in which case the |
16 | authorization expires two (2) years from the issue date of the insurance policy, and when signed |
17 | in connection with a claim for benefits under any insurance policy, the authorization shall be |
18 | valid during the pendency of that claim. Any revocation shall be transmitted in writing. |
19 | (e) Except as specifically provided by law, an individual's confidential health care |
20 | information shall not be given, sold, transferred, or in any way relayed to any other person not |
21 | specified in the consent form or notice meeting the requirements of subsection (d) of this section |
22 | without first obtaining the individual's additional written consent on a form stating the need for |
23 | the proposed new use of this information or the need for its transfer to another person. |
24 | (f) Nothing contained in this chapter shall be construed to limit the permitted disclosure |
25 | of confidential health care information and communications described in subsection (b) of this |
26 | section. |
27 | SECTION 2. Section 23-17.26-3 of the General Laws in Chapter 23-17.26 entitled |
28 | "Comprehensive Discharge Planning" is hereby amended to read as follows: |
29 | 23-17.26-3. Comprehensive discharge planning. |
30 | (a) On or before January 1, 2017, each hospital and freestanding, emergency-care facility |
31 | operating in the state of Rhode Island shall submit to the director a comprehensive discharge plan |
32 | that includes: |
33 | (1) Evidence of participation in a high-quality, comprehensive discharge-planning and |
34 | transitions-improvement project operated by a nonprofit organization in this state; or |
| LC004868/SUB A/2 - Page 8 of 13 |
1 | (2) A plan for the provision of comprehensive discharge planning and information to be |
2 | shared with patients transitioning from the hospital's or freestanding, emergency-care facility's |
3 | care. Such plan shall contain the adoption of evidence-based practices including, but not limited |
4 | to: |
5 | (i) Providing education in the hospital or freestanding, emergency-care facility prior to |
6 | discharge; |
7 | (ii) Ensuring patient involvement such that, at discharge, patients and caregivers |
8 | understand the patient's conditions and medications and have a point of contact for follow-up |
9 | questions; |
10 | (iii) With patient consent, attempting to notify the person(s) listed as the patient's |
11 | emergency contacts and recovery coach before discharge. If the patient refuses to consent to the |
12 | notification of emergency contacts, such refusal shall be noted in the patient's medical record; |
13 | (iv) Attempting to identify patients' primary care providers and assisting with scheduling |
14 | post-discharge follow-up appointments prior to patient discharge; |
15 | (v) Expanding the transmission of the department of health's continuity-of-care form, or |
16 | successor program, to include primary care providers' receipt of information at patient discharge |
17 | when the primary care provider is identified by the patient; and |
18 | (vi) Coordinating and improving communication with outpatient providers. |
19 | (3) The discharge plan and transition process shall include recovery planning tools for |
20 | patients with substance-use disorders, opioid overdoses, and chronic addiction, which plan and |
21 | transition process shall include the elements contained in subsections (a)(1) or (a)(2), as |
22 | applicable. In addition, such discharge plan and transition process shall also include: |
23 | (i) That, with patient consent, each patient presenting to a hospital or freestanding, |
24 | emergency-care facility with indication of a substance-use disorder, opioid overdose, or chronic |
25 | addiction shall receive a substance-abuse use evaluation, in accordance with the standards in |
26 | subsection (a)(4)(ii), before discharge. Prior to the dissemination of the standards in subsection |
27 | (a)(4)(ii), with patient consent, each patient presenting to a hospital or freestanding, emergency- |
28 | care facility with indication of a substance-use disorder, opioid overdose, or chronic addiction |
29 | shall receive a substance-abuse use evaluation, in accordance with best practices standards, before |
30 | discharge; |
31 | (ii) That if, after the completion of a substance-abuse use evaluation, in accordance with |
32 | the standards in subsection (a)(4)(ii), the clinically appropriate inpatient and outpatient services |
33 | for the treatment of substance-use disorders, opioid overdose, or chronic addiction contained in |
34 | subsection (a)(3)(iv) are not immediately available, the hospital or freestanding, emergency-care |
| LC004868/SUB A/2 - Page 9 of 13 |
1 | facility shall provide medically necessary and appropriate services with patient consent, until the |
2 | appropriate transfer of care is completed; |
3 | (iii) That, with patient consent, pursuant to 21 C.F.R. § 1306.07, a physician in a hospital |
4 | or freestanding, emergency-care facility, who is not specifically registered to conduct a narcotic |
5 | treatment program, may administer narcotic drugs, including buprenorphine, to a person for the |
6 | purpose of relieving acute, opioid-withdrawal symptoms, when necessary, while arrangements |
7 | are being made for referral for treatment. Not more than one day's medication may be |
8 | administered to the person or for the person's use at one time. Such emergency treatment may be |
9 | carried out for not more than three (3) days and may not be renewed or extended; |
10 | (iv) That each patient presenting to a hospital or freestanding, emergency-care facility |
11 | with indication of a substance-use disorder, opioid overdose, or chronic addiction, shall receive |
12 | information, made available to the hospital or freestanding, emergency-care facility in accordance |
13 | with subsection (a)(4)(v), about the availability of clinically appropriate inpatient and outpatient |
14 | services for the treatment of substance-use disorders, opioid overdose, or chronic addiction, |
15 | including: |
16 | (A) Detoxification; |
17 | (B) Stabilization; |
18 | (C) Medication-assisted treatment or medication-assisted maintenance services, including |
19 | methadone, buprenorphine, naltrexone, or other clinically appropriate medications; |
20 | (D) Inpatient and residential treatment; |
21 | (E) Licensed clinicians with expertise in the treatment of substance-use disorders, opioid |
22 | overdoses, and chronic addiction; |
23 | (F) Certified recovery coaches; and |
24 | (v) That, when the real-time patient-services database outlined in subsection (a)(4)(vi) |
25 | becomes available, each patient shall receive real-time information from the hospital or |
26 | freestanding, emergency-care facility about the availability of clinically appropriate inpatient and |
27 | outpatient services. |
28 | (4) On or before January 1, 2017, the director of the department of health, with the |
29 | director of the department of behavioral healthcare, developmental disabilities and hospitals, |
30 | shall: |
31 | (i) Develop and disseminate, to all hospitals and freestanding, emergency-care facilities, a |
32 | regulatory standard for the early introduction of a recovery coach during the pre-admission and/or |
33 | admission process for patients with substance-use disorders, opioid overdose, or chronic |
34 | addiction; |
| LC004868/SUB A/2 - Page 10 of 13 |
1 | (ii) Develop and disseminate, to all hospitals and freestanding, emergency-care facilities, |
2 | substance-abuse use evaluation standards for patients with substance-use disorders, opioid |
3 | overdose, or chronic addiction; |
4 | (iii) Develop and disseminate, to all hospitals and freestanding, emergency-care facilities, |
5 | pre-admission, admission, and discharge regulatory standards, a recovery plan, and voluntary |
6 | transition process for patients with substance-use disorders, opioid overdose, or chronic addiction. |
7 | Recommendations from the 2015 Rhode Island governor's overdose prevention and intervention |
8 | task force strategic plan may be incorporated into the standards as a guide, but may be amended |
9 | and modified to meet the specific needs of each hospital and freestanding, emergency-care |
10 | facility; |
11 | (iv) Develop and disseminate best practices standards for health care clinics, urgent-care |
12 | centers, and emergency-diversion facilities regarding protocols for patient screening, transfer, and |
13 | referral to clinically appropriate inpatient and outpatient services contained in subsection |
14 | (a)(3)(iv); |
15 | (v) Develop regulations for patients presenting to hospitals and freestanding, emergency- |
16 | care facilities with indication of a substance-use disorder, opioid overdose, or chronic addiction to |
17 | ensure prompt, voluntary access to clinically appropriate inpatient and outpatient services |
18 | contained in subsection (a)(3)(iv); |
19 | (vi) Develop a strategy to assess, create, implement, and maintain a database of real-time |
20 | availability of clinically appropriate inpatient and outpatient services contained in subsection |
21 | (a)(3)(iv) of this section on or before January 1, 2018. |
22 | (5) On or before September 1, 2017, each hospital and freestanding, emergency-care |
23 | facility operating in the state of Rhode Island shall submit to the director a discharge plan and |
24 | transition process that shall include provisions for patients with a primary diagnosis of a mental |
25 | health disorder without a co-occurring substance use disorder. |
26 | (6) On or before January 1, 2018, the director of the department of health, with the |
27 | director of the department of behavioral healthcare, developmental disabilities and hospitals, shall |
28 | develop and disseminate mental health best practices standards for health care clinics, urgent care |
29 | centers, and emergency diversion facilities regarding protocols for patient screening, transfer, and |
30 | referral to clinically appropriate inpatient and outpatient services. The best practice standards |
31 | shall include information and strategies to facilitate clinically appropriate prompt transfers and |
32 | referrals from hospitals and freestanding, emergency-care facilities to less intensive settings. |
33 | (7) Nothing contained in this chapter shall be construed to limit the permitted disclosure |
34 | of confidential health care information and communications permitted under § 5-37.3- |
| LC004868/SUB A/2 - Page 11 of 13 |
1 | 4(b)(4)(i)(A) of the "confidentiality of health care communications and information act". |
2 | SECTION 3. Chapter 23-17.26 of the General Laws entitled "Comprehensive Discharge |
3 | Planning" is hereby amended by adding thereto the following section: |
4 | 23-17.26-5. Comprehensive patient consent form. |
5 | Each hospital and freestanding emergency-care facility shall incorporate patient consent |
6 | for certified peer recovery specialist and peer recovery coach services into a comprehensive |
7 | patient consent form to be implemented no later than January 1, 2019. |
8 | SECTION 4. Section 27-38.2-1 of the General Laws in Chapter 27-38.2 entitled |
9 | "Insurance Coverage for Mental Illness and Substance Abuse" is hereby amended to read as |
10 | follows: |
11 | 27-38.2-1. Coverage for treatment of mental health and substance use disorders. |
12 | [Effective April 1, 2018.]. |
13 | (a) A group health plan and an individual or group health insurance plan, and any |
14 | contract between the Rhode Island Medicaid program and any health insurance carrier, as defined |
15 | under chapters 18, 19, 20, and 41 of title 27, shall provide coverage for the treatment of mental |
16 | health and substance-use disorders under the same terms and conditions as that coverage is |
17 | provided for other illnesses and diseases. |
18 | (b) Coverage for the treatment of mental health and substance-use disorders shall not |
19 | impose any annual or lifetime dollar limitation. |
20 | (c) Financial requirements and quantitative treatment limitations on coverage for the |
21 | treatment of mental health and substance-use disorders shall be no more restrictive than the |
22 | predominant financial requirements applied to substantially all coverage for medical conditions in |
23 | each treatment classification. |
24 | (d) Coverage shall not impose non-quantitative treatment limitations for the treatment of |
25 | mental health and substance-use disorders unless the processes, strategies, evidentiary standards, |
26 | or other factors used in applying the non-quantitative treatment limitation, as written and in |
27 | operation, are comparable to, and are applied no more stringently than, the processes, strategies, |
28 | evidentiary standards, or other factors used in applying the limitation with respect to |
29 | medical/surgical benefits in the classification. |
30 | (e) The following classifications shall be used to apply the coverage requirements of this |
31 | chapter: (1) Inpatient, in-network; (2) Inpatient, out-of-network; (3) Outpatient, in-network; (4) |
32 | Outpatient, out-of-network; (5) Emergency care; and (6) Prescription drugs. |
33 | (f) Medication-assisted treatment or medication-assisted maintenance services of |
34 | substance-use disorders, opioid overdoses, and chronic addiction, including methadone, |
| LC004868/SUB A/2 - Page 12 of 13 |
1 | buprenorphine, naltrexone, or other clinically appropriate medications, is included within the |
2 | appropriate classification based on the site of the service. |
3 | (g) Payors shall rely upon the criteria of the American Society of Addiction Medicine |
4 | when developing coverage for levels of care and determining placements for substance-use |
5 | disorder treatment. |
6 | (h) Patients with substance-use disorders shall have access to evidence-based, non-opioid |
7 | treatment for pain, therefore coverage shall apply to medically necessary chiropractic care and |
8 | osteopathic manipulative treatment performed by an individual licensed under § 5-37-2. |
9 | (i) Consistent with coverage for medical and surgical services, a health plan as defined in |
10 | subsection (a) of this section shall cover clinically appropriate residential or inpatient services, |
11 | including detoxification and stabilization services, for the treatment of mental health and/or |
12 | substance use disorders, including alcohol use disorders, in accordance with this subsection. After |
13 | an assessment for substance use disorders, including alcohol use disorders, based upon the criteria |
14 | of the American Society of Addiction Medicine, or after an appropriate psychiatric assessment for |
15 | mental health disorders, conducted upon an emergency admission or for continuation of care, if a |
16 | qualified medical and/or clinical professional determines that residential or inpatient care, |
17 | including detoxification and stabilization services, is the most appropriate and least restrictive |
18 | level of care necessary, that professional shall, within twenty-four (24) hours of admission or at |
19 | least twenty-four (24) hours prior to the expiration of any previous authorization from the health |
20 | insurer, submit a treatment plan, including an estimated length of stay and such other information |
21 | as may be reasonably requested by the health insurer, to the patient's health insurer. The health |
22 | insurer shall conduct the utilization review in accordance with chapter 18.9 of title 27; provided, |
23 | that the patient shall be and remain presumptively covered for residential or inpatient services, |
24 | including detoxification and stabilization services, during the utilization review. On or before |
25 | March 1, 2021, the senate committee on health and human services, in conjunction with the house |
26 | committee on corporations, shall conduct a hearing on the impact of this subsection, to include |
27 | presentations from payors and providers, and other stakeholders at the discretion of the committee |
28 | chairs. This subsection shall apply only to covered services delivered within the health insurer's |
29 | provider network. Nothing herein prohibits the group health plan or health insurer from |
30 | conducting quality of care reviews. |
31 | SECTION 5. This act shall take effect on January 1, 2019. |
======== | |
LC004868/SUB A/2 | |
======== | |
| LC004868/SUB A/2 - Page 13 of 13 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO HEALTH AND SAFETY -- INSURANCE COVERAGE FOR MENTAL | |
ILLNESS AND SUBSTANCE ABUSE | |
*** | |
1 | This act would provide that patients with mental health and/or substance use disorders are |
2 | presumptively eligible for emergency admission practices or for continuation of care for clinically |
3 | appropriate residential or inpatient services. The act would also clarify when it is appropriate for a |
4 | health care provider to disclose protected health information. |
5 | This act would take effect on January 1, 2019. |
======== | |
LC004868/SUB A/2 | |
======== | |
| LC004868/SUB A/2 - Page 14 of 13 |